A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement Inhibitors
Clinical trial NCT04432584 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04432584
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-30
- Primary completion
- 2027-04-18
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.